600+ Companies
Established hub
Deals 2018 Q1
30 investments
2 acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Bloomberg Business

Valeant’s Rebound Falters After Key Drug Is Rejected

Stock markets Earnings
PE Hub

Verrica Pharmaceuticals goes public

Stock markets Health
@cyantist via Bloomberg Business

The Women’s Libido Pill Is Back, and So Is the Controversy

Health Diversity
Bloomberg Business

Drugmaker Revives Female Libido Pill at Half the Price

Health Costs

TraceLink just landed $60 million more to eliminate counterfeit prescription drugs

Funding Health
PE Hub

ACON and Humus Capital acquire Biosidus

Global Funding Apps & Services

SK Capital Partners to Acquire Performance Additives and Intermediates Maker SI Group

Manufacturing Funding

With $40M Banked, Escient Building for Fast Move to Human Trials

PE Hub

SK Capital buys SI Group

Funding Strategy
MedCity News

CRISPR clinical trial hits regulatory speedbump


FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

Health Science
Bloomberg Business

Pharma Companies Race to Find Wonder Drug for Obesity-Linked Liver Disease

Health Earnings

Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined

Health Stock markets Science
PE Hub

Leerink Revelation Partners and Industry Ventures-led investors acquires Three Arch's shares in AcelRx

Funding Strategy Health
VCCircle Network

Vivimed's bulk-drugs unit to buy Hungarian contract manufacturing firm


MEI Pharma Raises $75M

Health Funding

Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More

Health Science
PE Hub

Escient Pharmaceuticals rakes in $40 mln Series A

Science Funding Health

Escient Pharmaceuticals Finds $40M

Funding Health
PE Hub

CStone Pharma raises $260 mln

Funding Health Asia